Nemes Rush Group
GEHC icon

Nemes Rush Group’s GE HealthCare GEHC Stock Holding History

Nemes Rush Group’s Portfolio GEHC Stock Details GEHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$13.8K Sell
211
-23
-10% -$1.56K ﹤0.01% 517
2026
Q2 		$15K Sell
234
-23
-9% -$1.51K ﹤0.01% 522
2026
Q1 		$18.3K Buy
257
+20
+8% +$1.58K ﹤0.01% 479
2025
Q4 		$19.4K Buy
237
+16
+7% +$1.25K ﹤0.01% 471
2025
Q3 		$16.6K Sell
221
-609
-73% -$45.4K ﹤0.01% 440
2025
Q2 		$61.5K Hold
830
– – 0.01% 290
2025
Q1 		$67K Sell
830
-19
-2% -$1.63K 0.01% 283
2024
Q4 		$66.3K Buy
849
+611
+257% +$51.9K 0.01% 276
2024
Q3 		$21.7K Sell
238
-262
-52% -$22K ﹤0.01% 337
2024
Q2 		$39K Buy
500
+262
+110% +$21.4K 0.01% 283
2024
Q1 		$21.7K Hold
238
– – ﹤0.01% 368
2023
Q4 		$18.4K Sell
238
-91
-28% -$6.37K ﹤0.01% 354
2023
Q3 		$22.4K Sell
329
-35
-10% -$2.55K ﹤0.01% 329
2023
Q2 		$29.6K Buy
+364
New +$29K 0.01% 319

Other funds holding GEHC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Perpetual Ltd
Perpetual Ltd Sydney, New South Wales, Australia $6.57B AUM 14.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Locust Wood Capital Advisers
Locust Wood Capital Advisers New York $4.43B AUM 19.95% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return

Nemes Rush Group's GEHC Position: Q3 2026 in Review

Nemes Rush Group reduced its GE HealthCare (GEHC) stake by 9.8% in Q3 2026, selling an estimated $1.56K and leaving 211 shares worth $13.8K. The position accounts for ﹤0.01% of the portfolio, ranked #517.

Nemes Rush Group first reported a position in GEHC in Q2 2023 and has held it in 14 quarters since. The position peaked at $67K in Q1 2025. 657 funds tracked by Wall St. Rank hold GEHC as of Q3 2026.

  • Nemes Rush Group held 211 shares of GE HealthCare worth $13.8K as of Q3 2026.
  • Nemes Rush Group sold 23 GE HealthCare shares in Q3 2026, an estimated $1.56K.
  • GE HealthCare made up ﹤0.01% of Nemes Rush Group's portfolio in Q3 2026, its #517 holding.
  • Nemes Rush Group first reported a position in GE HealthCare in Q2 2023 and has held it in 14 quarters since.
  • Nemes Rush Group's GE HealthCare position peaked at $67K in Q1 2025.
  • 657 funds tracked by Wall St. Rank held GE HealthCare as of Q3 2026.

Based on Nemes Rush Group's 13F filing for Q3 2026, filed 4 Nov 2026.